trending Market Intelligence /marketintelligence/en/news-insights/trending/b9GQiy9ltd_9wycVxiznMA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Australia's Respiri conducts A$3.2M private placement

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Australia's Respiri conducts A$3.2M private placement

Melbourne, Australia-based Respiri Ltd. issued 40 million new shares in a private placement to investors to raise A$3.2 million.

The medical device company sold the shares at 8 Australian cents per share.

Respiri said the capital raising provides the company with financial capability to produce and launch its wheezo product in early 2019. Wheezo is a device for managing asthma that also comes with a companion mobile application.

Meanwhile, Respiri also plans to undertake a share purchase plan to eligible existing stockholders to raise up to an additional A$1 million. The record date for eligible shareholders to participate in the plan will be Dec. 17.